Sponsor Pipeline

Camurus AB Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Phase 3
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT05050942
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With…		 date change Primary completion pushed: 2026-07 -> 2026-11
2026-07-29 NCT05050942
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With…		 date change Completion pushed: 2028-07 -> 2028-11
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05050942 A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With… Gastro-enteropancreatic Neuroendocrine Tumor Active, Not Recruiting
Phase 2/3
NCT05281328 A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients… Polycystic Liver Disease Active, Not Recruiting
Not specified
NCT07583563 An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly Acromegaly Recruiting
Get alerts when Camurus AB's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free